Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single ascending dose study of AVE0657 in obstructive sleep apnea hypopnea syndrome
2007-002174-58Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obstructive sleep apnea hypopnea syndrome (OSAHS) comparing AVE0657 with Placebo (2 arms). Primary endpoint: Apnea Hypopnea Index change Day 2 vs baseline. Started Aug 2007; status: completed.
02
Drugs
AVE-0657
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on 2007-002174-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002174-58.